Answers are grounded in this paper and cite their sources.
This analysis demonstrates uptake differences of cisplatin in cancer cells, suggesting new insights into treatment effectiveness.
A versatile tool to unravel the uptake diversity of a front-line anticancer drug, cisplatin, within a cancer cell population is proposed herein based on single-cell inductively coupled plasma mass spectrometry....
No takes yet. Share an insight, caveat, or question.
Szymańska et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: